Respiratory syncytial virus
Showing 1 - 25 of >10,000
Respiratory Syncytial Virus Disease in Infants and Toddlers
Not yet recruiting
- Respiratory Syncytial Virus Infections
- (no location specified)
Jul 27, 2023
Respiratory Syncytial Virus Infection Trial (Sisunatovir, Placebo)
Not yet recruiting
- Respiratory Syncytial Virus Infection
- Sisunatovir
- Placebo
- (no location specified)
Oct 6, 2023
Respiratory Syncytial Virus Infections Trial in Saint Petersburg (RSV/Flu-01E low dose, RSV/Flu-01E high dose, Placebo)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSV/Flu-01E low dose
- +2 more
-
Saint Petersburg, Russian FederationSmorodintsev Research Institute of Influenza
Jul 24, 2023
Respiratory Syncytial Virus Infections Trial (Placebo, Active)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- Placebo
- Active
- (no location specified)
Oct 20, 2023
Respiratory Syncytial Virus Infections Trial in Adelaide (Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /,
Active, not recruiting
- Respiratory Syncytial Virus Infections
- Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /placebo
- +2 more
-
Herston, Queensland, Australia
- +1 more
Feb 1, 2023
Burden of Respiratory Syncytial Virus in Sweden: A Retrospective
Active, not recruiting
- Respiratory Syncytial Virus (RSV)
- (no location specified)
Nov 10, 2022
Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus Trial in Rolling Hills Estates, Miami,
Recruiting
- Respiratory Syncytial Virus Infection
- +2 more
- RSV/hMPV vaccine candidate Dose L
- +3 more
-
Rolling Hills Estates, California
- +2 more
Nov 14, 2023
Respiratory Syncytial Virus Trial in London (Molnupiravir, Placebo, RSV A Memphis 37b)
Recruiting
- Respiratory Syncytial Virus
- Molnupiravir
- +2 more
-
London, London, City Of, United KingdomhVIVO Services ( Site 0001)
Feb 2, 2023
RESCEU: Defining the Burden of RSV Disease
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSV Infection
- venepuncture
- nasopharyngeal swab
-
Oxford, Oxfordshire, United KingdomUniversity of Oxford
Oct 25, 2022
Respiratory Syncytial Virus Trial in Panama, United States (mRNA-1345, Placebo)
Not yet recruiting
- Respiratory Syncytial Virus
- mRNA-1345
- Placebo
-
Banning, California
- +20 more
Oct 18, 2023
Respiratory Syncytial Virus Infection Trial in Carolina, Guayama, San Juan (RSVt Vaccine, Control Group)
Recruiting
- Respiratory Syncytial Virus Infection
- RSVt Vaccine
- Control Group
-
Carolina, Puerto Rico
- +2 more
Feb 2, 2023
Respiratory Syncytial Virus Infections Trial in Baltimore, Laurel (RSV ?NS2 ?1313 I1314L Vaccine, Placebo)
Recruiting
- Respiratory Syncytial Virus Infections
- RSV ΔNS2 Δ1313 I1314L Vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Dec 2, 2022
Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe
Not yet recruiting
- Respiratory Syncytial Viruses
- Prior standard of care receipt of Pfizer's ABRYSVO vaccine
- (no location specified)
Oct 5, 2023
Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, PCV20)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- PCV20
- (no location specified)
May 18, 2023
Respiratory Syncytial Virus Infections Trial in United States (AZM Group, Control Group)
Recruiting
- Respiratory Syncytial Virus Infections
- AZM Group
- Control Group
-
Birmingham, Alabama
- +4 more
Jun 16, 2022
RESPIRATORY SYNCYTIAL VIRUS (RSV) Trial (Substudy A (Study Intervention), Substudy A (Placebo), Substudy B)
Not yet recruiting
- RESPIRATORY SYNCYTIAL VIRUS (RSV)
- Substudy A (Study Intervention)
- +2 more
- (no location specified)
Apr 24, 2023
Respiratory Syncytial Virus Infections Trial (Nirsevimab)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- (no location specified)
Jun 24, 2022
Health and Economic Burden of RSV Amongst Hospitalized Children
Recruiting
- Respiratory Syncytial Virus Infections
-
Amman, JordanJordan University Hospital
Dec 13, 2022
Respiratory Syncytial Virus Infection Trial in Shanghai (Sisunatovir)
Not yet recruiting
- Respiratory Syncytial Virus Infection
-
Shanghai, Shanghai, ChinaHuashan Hospital
Aug 4, 2023
Respiratory Syncytial Virus Infections Trial in London (RV299, Placebo, Midazolam)
Completed
- Respiratory Syncytial Virus Infections
- RV299
- +2 more
-
London, Greater London, United KingdomRichmond Pharmacology Ltd
Sep 11, 2023
Respiratory Syncytial Virus Infections Trial in Cincinnati (PIV5-vectored RSV Vaccine (BLB-201) Low Dose, PIV5-vectored RSV
Not yet recruiting
- Respiratory Syncytial Virus Infections
- PIV5-vectored RSV Vaccine (BLB-201) Low Dose
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 20, 2022
Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic
Completed
- RSV Infection
- Medical records analysis
- Comparison of cohorts
-
Bron, FranceGroupement Hospitalier EST - Hospices Civils de Lyon
Apr 26, 2022
Respiratory Syncytial Viruses Trial in London (MK-1654, Placebo, RSV-A Memphis 37b)
Completed
- Respiratory Syncytial Viruses
- Clesrovimab
- +2 more
-
London, United KingdomHVIVO Services Ltd ( Site 0001)
Aug 29, 2022
Infant RSV Infections and Health-related Quality of Life of
Recruiting
- RSV Infection
- +4 more
- cohort study
-
Munich, Bavaria, GermanyEFCNI
Oct 14, 2022